• Antiplatelet Trialists’ Collaboration (1988). Secondary prevention of vascular disease by prolonged antiplatelet treatment. British Medical Journal, 296, 320331.
  • Balis, F.M., Lester, C.M., Chrousos, G.P., Heideman, R.L., Poplack, D.G. (1987). Differences in cerebrospinal fluid penetration of corticosteroids: possible relationship to the prevention of meningeal leukaemia. Journal of Clinical Oncology, 5, 202207.
  • Belgaumi, A.F., Al-Bakrah, M., Al-Mahr, M., Al-Jefri, A., Al-Musa, A.R., Saleh, M., Salim, M.F., Osman, M., Osman, L., El-Solh, H. (2003). Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin. Cancer, 97, 28982903.
  • Bostrom, B.C., Sensel, M.R., Sather, H.N., Gaynon, P.S., Mei, K.L., Johnston, K., Erdmann, G.R., Gold, S., Heerema, N., Hutchinson, R.J., Provisor, A.J. & Trigg, M.E. (2003). Dexamethasone versus prednisolone and daily oral versus weekly intravenous mercaptopurine for patients with standard risk acute lymphoblastic leukaemia. Blood, 101, 38093817.
  • Chessells, J.M., Richards, S.M., Bailey, C.C., Lilleyman, J.S., Eden, O.B. (1995a). Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL Trials. British Journal of Haematology, 89, 364372.
  • Chessells, J.M., Bailey, C., Richards, S.M. (1995b). Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia. Lancet, 345, 143148.
  • Childhood ALL Collaborative Group (1996). Duration and Intensity of maintenance chemotherapy in acute lymphoblastic leukaemia. Lancet, 347, 17831788.
  • Eden, O.B., Harrison, G., Richards, S., Lilleyman, J.S., Bailey, C.C., Chessells, J.M., Hann, I.M., Hill, F.G. & Gibson, B.E. (2000). Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood lymphoblastic leukaemia 1980–1997. Leukaemia, 14, 23072320.
  • Hann, I., Vora, A., Richards, S., Hill, F., Gibson, B., Lilleyman, J., Kinsey, S., Mitchell, C.D. & Eden, O.B. (2000). Benefits of Intensified treatment for all children with acute lymphoblastic leukaemia: results from the MRC UKALL XI and MRC ALL 97 randomized trials. Leukaemia, 14, 356363.
  • Hann, I., Vora, A., Harrison, G., Harrison, C., Eden, O.B., Hill, F., Gibson, B., Richards, S. (2001). Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. British Journal of Haematology, 113, 103114.
  • Holland, J.F., Glidewell, O. (1972). Chemotherapy of acute lymphoblastic leukaemia of childhood. Cancer, 30, 14801487.
  • Hurwitz, C.A., Silverman, L.B., Schorin, M.A., Clavell, L.A., Dalton, V.K., Glick, K.M., Gelber, R.D., Sallan, S.E. (2000). Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia. Cancer, 88, 19641969.
  • Jones, B., Freeman, A.I., Shuster, J.J., Jacquillat, C., Weil, M., Pochedly, C., Sinks, L., Chevalier, L., Maurer, H.M., Koch, K. (1991). Lower incidence of meningeal leukaemia when prednisolone is replaced by dexamethasone in the treatment of acute lymphoblastic leukaemia. Medical and Pediatric Oncology, 19, 269275.
  • Kaspers, G.J., Veerman, A.J., Popp-Snijders, C., Lomecky, M., Van-Zantwijk, C.H., Swinkels, L.M. & Van-Werin, E.R. (1996). Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Medical and Pediatric Oncology, 27, 114121.
  • Schrappe, M., Camitta, B., Pui, C.H., Eden, T., Gaynon, P., Gustafsson, G., Janka-Schaub, G.E., Kamps, W., Masera, G., Sallan, S., Tsuchida, M. & Vilmer, E. (2000). Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukaemia, 14, 21932194.
  • Silverman, L.B., Gelber, R.D., Kimball Dalton, V., Asselin, B.L., Barr, R.D., Clavell, L.A., Hurwitz, C.A., Moghrabi, A., Samson, Y., Schorin, M.A., Arkin, S., Declerck, L., Cohen, H.J., Sallan, S.E. (2001). Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium protocol 91-01. Blood, 97, 12111218.
  • Veerman, A.J., Hahlen, K., Kamps, W.A., Van Leeuwen, E.F., De Vaan, G.A., Solbu, G. & Sucic, S. (1996). High cure rate with a moderately intensive treatment regimen in non-high risk childhood acute lymphoblastic leukaemia: results of protocol ALL VI from the Dutch Childhood Leukaemia Study Group. Journal of Clinical Oncology, 14, 911918.